PortfoliosLab logo
MMYT vs. MLTX
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between MMYT and MLTX is 0.14, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Performance

MMYT vs. MLTX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in MakeMyTrip Limited (MMYT) and MoonLake Immunotherapeutics (MLTX). The values are adjusted to include any dividend payments, if applicable.

Loading data...

Key characteristics

Sharpe Ratio

MMYT:

0.61

MLTX:

-0.10

Sortino Ratio

MMYT:

1.07

MLTX:

0.22

Omega Ratio

MMYT:

1.13

MLTX:

1.03

Calmar Ratio

MMYT:

0.97

MLTX:

-0.10

Martin Ratio

MMYT:

2.57

MLTX:

-0.25

Ulcer Index

MMYT:

11.20%

MLTX:

18.76%

Daily Std Dev

MMYT:

55.11%

MLTX:

50.23%

Max Drawdown

MMYT:

-73.45%

MLTX:

-64.60%

Current Drawdown

MMYT:

-15.32%

MLTX:

-38.99%

Fundamentals

Market Cap

MMYT:

$11.08B

MLTX:

$2.45B

EPS

MMYT:

$0.83

MLTX:

-$2.27

PS Ratio

MMYT:

11.32

MLTX:

0.00

PB Ratio

MMYT:

9.21

MLTX:

6.01

Total Revenue (TTM)

MMYT:

$732.87M

MLTX:

$101.85K

Gross Profit (TTM)

MMYT:

$429.69M

MLTX:

$22.81K

EBITDA (TTM)

MMYT:

$122.64M

MLTX:

-$118.68M

Returns By Period

In the year-to-date period, MMYT achieves a -9.15% return, which is significantly higher than MLTX's -28.05% return.


MMYT

YTD

-9.15%

1M

-3.08%

6M

-10.60%

1Y

33.15%

3Y*

51.68%

5Y*

45.79%

10Y*

17.98%

MLTX

YTD

-28.05%

1M

-3.04%

6M

-28.17%

1Y

-5.16%

3Y*

82.78%

5Y*

N/A

10Y*

N/A

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


MakeMyTrip Limited

MoonLake Immunotherapeutics

Go deeper with the Portfolio Analysis tool — backtest performance, assess risk, compare to benchmarks, and more

Risk-Adjusted Performance

MMYT vs. MLTX — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

MMYT
The Risk-Adjusted Performance Rank of MMYT is 7272
Overall Rank
The Sharpe Ratio Rank of MMYT is 7272
Sharpe Ratio Rank
The Sortino Ratio Rank of MMYT is 6767
Sortino Ratio Rank
The Omega Ratio Rank of MMYT is 6565
Omega Ratio Rank
The Calmar Ratio Rank of MMYT is 8383
Calmar Ratio Rank
The Martin Ratio Rank of MMYT is 7676
Martin Ratio Rank

MLTX
The Risk-Adjusted Performance Rank of MLTX is 4444
Overall Rank
The Sharpe Ratio Rank of MLTX is 4545
Sharpe Ratio Rank
The Sortino Ratio Rank of MLTX is 4242
Sortino Ratio Rank
The Omega Ratio Rank of MLTX is 4141
Omega Ratio Rank
The Calmar Ratio Rank of MLTX is 4444
Calmar Ratio Rank
The Martin Ratio Rank of MLTX is 4646
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

MMYT vs. MLTX - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for MakeMyTrip Limited (MMYT) and MoonLake Immunotherapeutics (MLTX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The current MMYT Sharpe Ratio is 0.61, which is higher than the MLTX Sharpe Ratio of -0.10. The chart below compares the historical Sharpe Ratios of MMYT and MLTX, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading data...

Go to the full Sharpe Ratio tool to analyze any stock or portfolio. Customize time frames, set your own risk-free rate, and more

Dividends

MMYT vs. MLTX - Dividend Comparison

Neither MMYT nor MLTX has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

MMYT vs. MLTX - Drawdown Comparison

The maximum MMYT drawdown since its inception was -73.45%, which is greater than MLTX's maximum drawdown of -64.60%. Use the drawdown chart below to compare losses from any high point for MMYT and MLTX.


Loading data...

Go to the full Drawdowns tool for more analysis options, including inflation-adjusted drawdowns, and more

Volatility

MMYT vs. MLTX - Volatility Comparison

MakeMyTrip Limited (MMYT) has a higher volatility of 17.71% compared to MoonLake Immunotherapeutics (MLTX) at 15.82%. This indicates that MMYT's price experiences larger fluctuations and is considered to be riskier than MLTX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading data...

Financials

MMYT vs. MLTX - Financials Comparison

This section allows you to compare key financial metrics between MakeMyTrip Limited and MoonLake Immunotherapeutics. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0050.00M100.00M150.00M200.00M250.00M20212022202320242025
267.36M
0
(MMYT) Total Revenue
(MLTX) Total Revenue
Values in USD except per share items